Your browser doesn't support javascript.
loading
Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma.
Karam, Jose A; Msaouel, Pavlos; Haymaker, Cara L; Matin, Surena F; Campbell, Matthew T; Zurita, Amado J; Shah, Amishi Y; Wistuba, Ignacio I; Marmonti, Enrica; Duose, Dzifa Y; Parra, Edwin R; Soto, Luisa Maren Solis; Laberiano-Fernandez, Caddie; Lozano, Marisa; Abraham, Alice; Hallin, Max; Chin, Curtis D; Olson, Peter; Der-Torossian, Hirak; Yan, Xiaohong; Tannir, Nizar M; Wood, Christopher G.
Afiliação
  • Karam JA; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. jakaram@mdanderson.org.
  • Msaouel P; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. jakaram@mdanderson.org.
  • Haymaker CL; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. PMsaouel@mdanderson.org.
  • Matin SF; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. PMsaouel@mdanderson.org.
  • Campbell MT; David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas, MD Anderson Cancer Center, Houston, TX, 77030, USA. PMsaouel@mdanderson.org.
  • Zurita AJ; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Shah AY; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Wistuba II; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Marmonti E; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Duose DY; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Parra ER; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Soto LMS; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Laberiano-Fernandez C; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Lozano M; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Abraham A; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Hallin M; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Chin CD; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Olson P; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Der-Torossian H; Mirati Therapeutics, Inc., San Diego, CA, 92121, USA.
  • Yan X; Mirati Therapeutics, Inc., San Diego, CA, 92121, USA.
  • Wood CG; Mirati Therapeutics, Inc., San Diego, CA, 92121, USA.
Nat Commun ; 14(1): 2684, 2023 05 10.
Article em En | MEDLINE | ID: mdl-37164948
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos